„Innovative bioinformatics partnerships by EMBL-EBI: The AlphaFold, OpenTargets, and COVID19 Data Platform examples.„
The European Bioinformatics Institute (EMBL-EBI) maintains the world’s most comprehensive range of freely available and up-to-date molecular data resources. Developed in collaboration with our colleagues worldwide, our services promote to share data, perform complex queries and analyse the results in different ways.
In my presentation I like to highlight some recent examples of innovative EMBL-EBI partnerships:
- Open Targets is an innovative, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation.
- The European COVID-19 Data Platform facilitates data sharing and analysis in order to accelerate coronavirus research, which is essential to respond to the COVID-19 pandemic. The European Commission and EMBL’s European Bioinformatics Institute (EMBL-EBI), together with EU Member States and research partners such as ELIXIR, operate a dedicated European COVID-19 Data Platform that enables the rapid collection and comprehensive data sharing of available research data from different sources for the European and global research communities.
- AlphaFold, a state-of-the-art AI system developed by DeepMind, is able to computationally predict protein structures with unprecedented accuracy and speed. These predictions are being made freely and openly available to the global scientific community in partnership with EMBL’s European Bioinformatics Institute (EMBL-EBI), opening up new and exciting research avenues to dramatically deepen our understanding of human health, disease and our environment, with implications for areas like drug design and sustainability.